InvestorsHub Logo
Followers 71
Posts 5632
Boards Moderated 0
Alias Born 12/27/2005

Re: None

Friday, 05/10/2024 9:01:38 AM

Friday, May 10, 2024 9:01:38 AM

Post# of 20371
Get a load of the stock analyst calling into the CEO conference calls pretending to be a stock analyst. He said he had a side deal with the CEO, so no wonder why he was blatantly pumping the stock. This was just his first long winded question and there were a LOT more.

Note: Where the ellipsis are, the transcriber took out the umms and ahhhs. Otherwise it would be unreadable. Sounded very nervous or confused when you listen to the audio.


http://content.stockpr.com/amarantus/media/782786d417b8894297ed7f45f31a9e42.pdf

Operator: (Operator instructions.) Our next question comes from the line of John Petrosino with
JWP Incorporated. Please proceed with your question.
: Good afternoon, gentlemen. I want to thank you very much for taking the time
out to have this conference call. …. I also wanted to congratulate Amarantus on the
outstanding milestone achievements that they have accomplished in 2013. Obviously
2013 was a very challenging year for anybody involved with the …. Things are
moving in the right direction very nicely, both on the diagnostic side, as well as the
therapeutic side. Congratulations to the new additions, Dr. Lowe being one, Dr. Bier
being another with respect to the Board of Directors and the Board of Advisors. Dr.
Simon, as well, congratulations to you.
All that said and done, my question was pretty much answered by those who were
opposed by both Joseph Napotano, as well as another individual, … All that said, a
couple of things are in the back of my mind. Is there a timeframe, Gerald, that we are
looking at with respect to an announcement of the second orphan indication? Is there